Biotech startups in Israel
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Remepy | Ramat Gan | Series A | $36.0M | 2026-08-12 |
| Phytolon | Yoqne`am `illit | Series B | $23.6M | 2026-05-26 |
| Scala Biodesign | Tel Aviv | Series A | $16.0M | 2026-03-31 |
| MDClone | Be'er Sheva | Series C | $63.0M | 2022-03-01 |
| CytoReason | Tel Aviv | Series B | $80.0M | 2024-07-17 |
| Imagene AI | Tel Aviv | Series B | $23.0M | 2025-07-01 |
| Accellix | Jerusalem | Series E | $10.0M | 2021-12-13 |
| Protai | Tel Aviv | Seed | $12.0M | 2023-03-15 |
8 rows of the CSV in 5 of its 18 columns.
- The 189 biotech startups in Israel have raised $1.9B in total.
- 11 of them closed their most recent round in the last 12 months, $123.4M combined.
- The largest of those rounds is Remepy's $36.0M Series A, dated August 2026.
- The most recent is Undecimal Bio's $18.0M seed round on 12 October 2026.
- MassChallenge is an investor in 4 of them, more than any other fund.
- Health care is the most common other sector, with 136 companies (72%).
- 23% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 1 to 10 employees (45% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
17 of 189| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Remepy | Remepy develops hybrid drugs that combine multiple therapeutic approaches for biotechnology research. | Artificial intelligence | Ramat Gan | Series A | $36.0M | 2026-08-12 | $51.0M | Samsung NEXT, NFX, Vine Ventures +2 | 11 to 50 | 2022 |
| Phytolon | Phytolon supplies natural food colors of high quality at low cost. | Biotech | Yoqne`am `illit | Series B | $23.6M | 2026-05-26 | $43.7M | MassChallenge, Trendlines Group, Millenium Food-Tech | 11 to 50 | 2018 |
| Scala Biodesign | Scala Biodesign provides partners with a computational solution that increases the value of proteins and speeds their development. | Artificial intelligence | Tel Aviv | Series A | $16.0M | 2026-03-31 | $26.2M | Intel Capital, Intel Ignite, TLV Partners | 1 to 10 | 2022 |
| CytoReason | CytoReason develops a cell-centered computational model of the human body to find patterns in biological data. | Artificial intelligence | Tel Aviv | Series B | $80.0M | 2024-07-17 | $100.0M | OurCrowd, Asymmetry Ventures, Pfizer | 101 to 250 | 2016 |
| DOT Compliance | DOT Compliance provides a ready-to-use cloud-based quality and compliance management solution for regulated industries. | Biotech | Ness Ziona | Series B | $17.5M | 2024-04-15 | Vertex Ventures, TPY Capital, Israel Growth Partners | 101 to 250 | 2007 | |
| EfA Technologies | EfA Technologies develops a programmable digital diagnostic lab-on-hand system. | Biotech | Caesarea | Seed | $6.5M | 2024-03-01 | eHealth Ventures | 1 to 10 | 2016 | |
| WeedOut | WeedOut is a biotechnology company that provides weed control solutions. | Biotech | Ness Ziona | Series A | $8.1M | 2024-02-20 | Syngenta Ventures, Radicle Growth, Clay Capital +1 | 11 to 50 | 2016 | |
| Gina Life | Gina Life develops AI-supported biomarker platforms for early detection in women's health. | Biotech | Haifa | Seed | $3.1M | 2023-08-29 | $3.1M | MassChallenge, Pitango VC, MassChallenge Israel +2 | 1 to 10 | 2020 |
| Quris | Quris provides an AI platform that predicts which drug candidates will safely work in humans. | Artificial intelligence | Tel Aviv | Seed | $9.0M | 2022-12-20 | $37.0M | SoftBank Vision Fund, iAngels, Fusion +1 | 11 to 50 | 2019 |
| NeuroBrave | NeuroBrave provides access to real-time cognitive and emotional states through everyday wearable devices. | Artificial intelligence | Tel Aviv | Angel | $300K | 2022-08-19 | Intel Ignite, Samurai Incubate, Italian Angels for Growth +2 | 11 to 50 | 2020 | |
| Accellix | Accellix provides an assay delivery platform. | Biotech | Jerusalem | Series E | $10.0M | 2021-12-13 | BroadOak Capital Partners | 51 to 100 | 2013 | |
| MobileODT | MobileODT develops AI-based medical devices for cervical cancer screening. | Artificial intelligence | Tel Aviv | Series C | $4.0M | 2020-08-12 | MedTech Innovator, OrbiMed, VU Venture Partners +2 | 11 to 50 | 2012 | |
| BIO-NEXUS | BIO-NEXUS develops medical devices and systems. | Biotech | Netanya | Series A | $3.0M | 2016-08-23 | $3.0M | Springtide Ventures | 51 to 100 | 2010 |
| Nutrinia | Nutrinia develops therapies for patients with intestinal failure. | Biotech | Ramat Gan | Series D | $30.0M | 2016-08-18 | OrbiMed, Pontifax, WuXi Healthcare Ventures +2 | 11 to 50 | 2003 | |
| Origene Seeds | Origene Seeds breeds new vegetable varieties. | Biotech | Rehovot | Seed | $10.3M | 2015-10-29 | Fortissimo Capital | 11 to 50 | 2004 | |
| Quiet Therapeutics | Quiet Therapeutics is a biotech company developing a proprietary nanoparticle-based drug delivery system. | Biotech | Ness Ziona | Series A | $12.0M | 2015-04-12 | Jerusalem Global Ventures, Arkin Capital | 1 to 10 | 2009 | |
| Treato | Treato collects patient-written health experiences from blogs and forums to reveal patient opinions. | Artificial intelligence | Or Yehuda | Series B | $14.5M | 2013-04-23 | Western Technology Investment, OrbiMed, REV +1 | 11 to 50 | 2008 |
Table 1. Biotech startups in Israel: the 17 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 189.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Remepy | Remepy develops hybrid drugs that combine multiple therapeutic approaches for biotechnology research. | Artificial intelligence | Ramat Gan | Series A | $36.0M | 2026-08-12 | $51.0M | Samsung NEXT, NFX, Vine Ventures +2 | 11 to 50 | 2022 |
| 2 | Phytolon | Phytolon supplies natural food colors of high quality at low cost. | Biotech | Yoqne`am `illit | Series B | $23.6M | 2026-05-26 | $43.7M | MassChallenge, Trendlines Group, Millenium Food-Tech | 11 to 50 | 2018 |
| 3 | Scala Biodesign | Scala Biodesign provides partners with a computational solution that increases the value of proteins and speeds their development. | Artificial intelligence | Tel Aviv | Series A | $16.0M | 2026-03-31 | $26.2M | Intel Capital, Intel Ignite, TLV Partners | 1 to 10 | 2022 |
Table 2. Biotech startups in Israel: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | MassChallenge | Startup accelerator | Boston, United States | 4 | 2% | 1 | Phytolon |
| 2 | OrbiMed | Private equity firm | New York, United States | 4 | 2% | ||
| 3 | OurCrowd | Venture capital firm | Jerusalem, Israel | 4 | 2% | ||
| 4 | Trendlines Group | Venture capital firm | Misgav, Israel | 3 | 2% | 1 | Phytolon |
| 5 | Pitango VC | Venture capital firm | Herzliya, Israel | 3 | 2% | ||
| 6 | Intel Ignite | Startup accelerator | Tel Aviv, Israel | 2 | 1% | 1 | Scala Biodesign |
| 7 | Ocean Azul Partners | Micro VC fund | Coral Gables, United States | 2 | 1% | ||
| 8 | ALIVE Israel HealthTech Fund | Venture capital firm | Tel Aviv, Israel | 2 | 1% | ||
| 9 | Firstime Venture Capital | Venture capital firm | Tel Aviv, Israel | 1 | 1% | 1 | Remepy |
| 10 | NFX | Startup accelerator | San Francisco, United States | 1 | 1% | 1 | Remepy |
| 11 | fresh.fund | Venture capital firm | Tel Aviv, Israel | 1 | 1% | 1 | Remepy |
| 12 | Vine Ventures | Venture capital firm | New York, United States | 1 | 1% | 1 | Remepy |
| 13 | Samsung NEXT | Corporate venture arm | Mountain View, United States | 1 | 1% | 1 | Remepy |
| 14 | Millenium Food-Tech | Venture capital firm | Tel Aviv, Israel | 1 | 1% | 1 | Phytolon |
| 15 | TLV Partners | Venture capital firm | Tel Aviv, Israel | 1 | 1% | 1 | Scala Biodesign |
Table 3. Biotech startups in Israel: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 136 | 72% | $1.7B |
| Software | 37 | 20% | $285.6M |
| Artificial intelligence | 22 | 12% | $276.7M |
| Hardware | 12 | 6% | $64.0M |
| Cybersecurity | 2 | 1% | |
| Energy | 2 | 1% | |
| Education | 1 | 1% | $3.4M |
| Fintech | 1 | 1% |
Table 4. Biotech startups in Israel by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Biotech startups in Israel by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Biotech startups in Israel by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 9% | $18.0M |
| August 2026 | 1 | 9% | $36.0M |
| June 2026 | 2 | 18% | $150K |
| May 2026 | 3 | 27% | $33.2M |
| March 2026 | 2 | 18% | $18.1M |
| February 2026 | 1 | 9% | $18.0M |
| December 2025 | 1 | 9% |
Table 7. Biotech startups in Israel: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 10 | 5% | $123.4M |
| 2025 | 10 | 5% | $85.4M |
| 2024 | 13 | 7% | $171.1M |
| 2023 | 17 | 9% | $185.3M |
| 2022 | 23 | 12% | $357.3M |
| 2021 | 28 | 15% | $822.3M |
Table 8. Biotech startups in Israel by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 4 | 2% |
| 2020 to 2022 | 40 | 21% |
| 2015 to 2019 | 77 | 41% |
| 2010 to 2014 | 26 | 14% |
| Before 2010 | 42 | 22% |
Table 9. Biotech startups in Israel by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 84 | 45% |
| 11 to 50 | 81 | 44% |
| 51 to 100 | 11 | 6% |
| 101 to 250 | 9 | 5% |
Table 10. Biotech startups in Israel by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Israel. On 16 November 2026 that is 189 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 17 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 189 rows: 55 have no round amount, 0 no city and 91 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Israel are on the list?
- 189, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 189 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.